deltatrials
Completed NA INTERVENTIONAL 2-arm NCT01398254

Femoral Versus Radial Access for Primary PCI (SAFARI-STEMI)

The Safety and Efficacy of Femoral Access Versus Radial for Primary Percutaneous Coronary Intervention in ST-Elevation Myocardial Infarction (SAFARI-STEMI Trial)

Sponsor: Ottawa Heart Institute Research Corporation

Conditions Myocardial Infarction STEMI
Interventions Primary Percutaneous Coronary Intervention (PPCI)
Updated 6 times since 2017 Last updated: Jan 25, 2019 Started: Jul 31, 2011 Primary completion: Dec 31, 2018 Completion: Jan 16, 2019
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT01398254, this NA trial focuses on Myocardial Infarction and STEMI and remains completed. Sponsored by Ottawa Heart Institute Research Corporation, it has been updated 6 times since 2011, reflecting limited change activity. This study contributes longitudinal data to the cardiovascular research landscape.

Status Flow

~Jan 2017 – ~Jun 2018 · 17 months · monthly snapshotRecruiting~Jun 2018 – ~Feb 2019 · 8 months · monthly snapshotRecruiting~Feb 2019 – ~Jan 2021 · 23 months · monthly snapshotCompleted~Jan 2021 – ~Jul 2024 · 42 months · monthly snapshotCompleted~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotCompleted~Sep 2024 – present · 22 months · monthly snapshotCompleted

Change History

6 versions recorded

  1. Sep 2024 — Present [monthly]

    Completed NA

  2. Jul 2024 — Sep 2024 [monthly]

    Completed NA

  3. Jan 2021 — Jul 2024 [monthly]

    Completed NA

  4. Feb 2019 — Jan 2021 [monthly]

    Completed NA

    Status: Recruiting → Completed

  5. Jun 2018 — Feb 2019 [monthly]

    Recruiting NA

▶ Show 1 earlier version

  1. Jan 2017 — Jun 2018 [monthly]

    Recruiting NA

    First recorded

Jul 2011

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Ottawa Heart Institute Research Corporation
Data source: Ottawa Heart Institute Research Corporation

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations